Lund, Sweden, December 15, 2025. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), today announced a reorganization of its European and International Commercial and Medical Affairs operations, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback